New Hair Growth Serum vs. Minoxidil for Hair Loss
Treatments studied
Part of Skin clinical trials.
This study compares a new peptide-based hair serum with minoxidil (a common hair-regrowth treatment) in people with androgenetic alopecia, a type of hair loss caused by genetics and hormones. The trial lasts 24 weeks and measures how well each treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with androgenetic alopecia (genetic hair loss) at a moderate stage or worse
- Able to keep the same hairstyle and hair color for 6 months
- Willing to stop hair-loss treatments and supplements for at least 3–6 months before starting
- Can attend all study visits over 24 weeks
- No major uncontrolled health conditions (liver, kidney, thyroid, heart, diabetes, anemia)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral (pill) form of minoxidil to help regrow hair in men with male-pattern baldness. Minoxidil is a known hair-growth medication, and this study evaluates whether taking it as a pill works safely and effectively.
This trial tests whether a low-dose oral form of minoxidil (a common hair-loss medicine) can help people with mild to severe male or female pattern baldness.
This trial tests whether a lotion containing a beneficial bacteria (Lactobacillus reuteri) can help with male or female pattern hair loss. The treatment is applied directly to the scalp.
This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.
This trial compares a topical (applied to the scalp) minoxidil with an oral (pill) version of minoxidil to treat male and female pattern baldness. It aims to find which method works better and is safer.
This trial tests a new gel made from a natural sugar molecule against a standard hair loss treatment (minoxidil). It aims to see which works better for people with mild to moderate hereditary hair loss.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.